Clinical Trial Update: A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 randomized trial evaluating the pharmacokinetic and pharmacodynamic properties of faster-acting insulin aspart in individuals with Type 1 diabetes, wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED